AU2000276362A1 - Composition for the treatment of diabetes - Google Patents

Composition for the treatment of diabetes

Info

Publication number
AU2000276362A1
AU2000276362A1 AU2000276362A AU7636200A AU2000276362A1 AU 2000276362 A1 AU2000276362 A1 AU 2000276362A1 AU 2000276362 A AU2000276362 A AU 2000276362A AU 7636200 A AU7636200 A AU 7636200A AU 2000276362 A1 AU2000276362 A1 AU 2000276362A1
Authority
AU
Australia
Prior art keywords
diabetes
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000276362A
Inventor
Robert B. Rieveley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2000276362A1 publication Critical patent/AU2000276362A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2000276362A 2000-06-30 2000-09-29 Composition for the treatment of diabetes Abandoned AU2000276362A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/608,272 US6291495B1 (en) 1997-02-24 2000-06-30 Method and composition for the treatment of diabetes
US09608272 2000-06-30
PCT/CA2000/001152 WO2002004024A1 (en) 2000-06-30 2000-09-29 Composition for the treatment of diabetes

Publications (1)

Publication Number Publication Date
AU2000276362A1 true AU2000276362A1 (en) 2002-01-21

Family

ID=24435759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000276362A Abandoned AU2000276362A1 (en) 2000-06-30 2000-09-29 Composition for the treatment of diabetes

Country Status (3)

Country Link
US (1) US6291495B1 (en)
AU (1) AU2000276362A1 (en)
WO (1) WO2002004024A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0996444B1 (en) * 1997-06-18 2007-03-07 SmithKline Beecham plc Treatment of diabetes with thiazolidinedione and metformin
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020028768A1 (en) * 1997-06-18 2002-03-07 Smithkline Beecham P.L.C. Treatment of diabetes with rosiglitazone and insulin
US20020016287A1 (en) * 1997-07-18 2002-02-07 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
EP1113804A2 (en) * 1998-09-17 2001-07-11 Akesis Pharmaceuticals, Inc. Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
KR200249057Y1 (en) * 2001-03-22 2001-10-19 김진환 Sewage backflow integrated into the lid and base. Odor Prevention Device
RU2311907C2 (en) * 2001-07-17 2007-12-10 Н-Джин Ресерч Лабораториз Инк. Synergetic pharmaceutical composition for prophylaxis and treatment of diabetes mellitus
AU2003226313A1 (en) * 2002-04-23 2003-11-10 Nutrition 21, Inc. Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
CN100367960C (en) * 2002-07-11 2008-02-13 武田药品工业株式会社 Process for producing coated preparation
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) * 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) * 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
UA80991C2 (en) * 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
US20040091544A1 (en) * 2002-11-08 2004-05-13 Ruff Michael D. Coated dibasic calcium phosphate
EP1588708A4 (en) 2003-01-29 2006-03-01 Takeda Pharmaceutical Process for producing coated preparation
CA2540225C (en) 2003-10-31 2012-03-06 Takeda Pharmaceutical Company Limited Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester
AR055563A1 (en) * 2005-02-25 2007-08-22 Takeda Pharmaceutical PIRIDIL COMPOUNDS ACETIC ACID, PHARMACEUTICAL AGENT AND USE OF THE COMPOUND TO PREPARE SUCH AGENT
EP3050568B1 (en) 2007-03-13 2020-12-02 JDS Therapeutics, LLC Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
AU2012223282B2 (en) 2011-03-01 2017-02-02 Nutrition 21, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
US20150196622A1 (en) * 2012-08-21 2015-07-16 Ali Nayer Materials and methods for modulating glucose uptake
US11865121B2 (en) 2016-02-11 2024-01-09 Nutrition21, LLC Chromium containing compositions for improving health and fitness

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320583A1 (en) 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach NEW GALENIC PREPARATION FORMS OF ORAL ANTIDIABETICS AND METHOD FOR THE PRODUCTION THEREOF
US4849405A (en) 1984-05-09 1989-07-18 Synthetic Blood Corporation Oral insulin and a method of making the same
US4963526A (en) 1984-05-09 1990-10-16 Synthetic Blood Corporation Oral insulin and a method of making the same
US5206219A (en) 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
US5422125A (en) 1993-07-12 1995-06-06 Baker Norton Pharmaceuticals, Inc. Method and composition for treatment of insulin resistance syndromes
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5595763A (en) 1995-07-19 1997-01-21 Quimica Farmaceutica Bayer S.A. Tungsten (VI) compositions for the oral treatment of diabetes mellitus
IT1276130B1 (en) 1995-11-14 1997-10-27 Gentili Ist Spa GLIBENCLAMIDE-METFORMIN ASSOCIATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND THEIR USE IN THE TREATMENT OF TYPE DIABETES MELLITUS
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6153632A (en) * 1997-02-24 2000-11-28 Rieveley; Robert B. Method and composition for the treatment of diabetes
GB9712866D0 (en) * 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
EP1039890B1 (en) 1997-12-08 2004-03-17 Bristol-Myers Squibb Company Novel salts of metformin and method
EP1113804A2 (en) * 1998-09-17 2001-07-11 Akesis Pharmaceuticals, Inc. Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders

Also Published As

Publication number Publication date
US6291495B1 (en) 2001-09-18
WO2002004024A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2001272849A1 (en) Composition for the treatment of osteoarthritis
AU2001292480A1 (en) Novel pyridazine compounds for the treatment of diabetes
AU2935200A (en) Compounds for the treatment of obesity
AU2001231104A1 (en) Methods for treating diabetes
AU2001233081A1 (en) Composition for treatment of stress
AU2001272852A1 (en) Composition for the treatment of migraine
AU2002359500A1 (en) Fabric treatment composition
AU2002258221A1 (en) Medicinal composition
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
AU2002241114A1 (en) Composition
AU2001274877A1 (en) Pest treatment composition
AU2001294673A1 (en) Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
AU2021601A (en) Composition for the treatment of dandruff
AU2002327440A1 (en) Treatment of type i diabetes
AU2002255354A1 (en) Minoxidil-containing liquid composition
AU2002365621A1 (en) Composition for treating the surface of the skin
AU2002354460A1 (en) Medicinal composition
AU2002349788A1 (en) Fiber treatment agent composition
AU2683500A (en) Compositions for the treatment of pain
AU2000272704A1 (en) Use of compounds for the treatment of obesity
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
EP1177789A3 (en) Use of phytanic acid for the treatment of diabetes